Van Cutsem E, Kang Y, Chung H, et al: Efficacy results from the ToGA trial; A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2) -positive advanced gastric cancer (GC). J Clin Oncol 27 (Suppl.):(ASCO 2009, abstrast LBA2409)
McCulloch P, Taggart T, Ochiai A, et al: c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 23: 304-309, 1997
Yano T, Doi T, Ohtsu A, et al: Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer. Oncol Rep 15: 65-71, 2006